D. Mirk et al. · MS Screening with Artificial Caffeine Receptors
1081
3.8 eq.) and 3-(N,N-dibenzylamino)propyl isocyanate (8) Subsequently, 6 N hydrochloric acid (100 ml) was added at
(174 mg, 0.62 mmol, 0.76 eq.) in dichloromethane (5 ml). ambient temperature and the solution was concentrated in
The reaction mixture was allowed to warm to ambient tem- vacuo. The remaining residue was crystallized twice from
perature, stirred overnight, and then diluted with ethyl acetate acetic acid (50 ml) and hydrochloride 6 was obtained in col-
(125 ml). The organic phase was subsequently washed with orless crystals (55.72 g, 0.174 mol, 64%).
0.1 M hydrochloric acid (75 ml) at 5 ◦C and brine (3×75 ml),
dried over anhydrous MgSO4 and concentrated in vacuo.
For the separation of the products the crude residue was ad-
sorbed on silica and subjected to column chromatography
(cyclohexane:ethyl acetate = 50:50) yielding receptor 3 [5]
(394 mg, 0.35 mmol, 43%) (RF (CH:EE = 50:50): 0.46) and
1 (115 mg (0.09 mmol, 11%) (RF (CH:EE = 50:50): 0.24) as
an off-white foam.
◦
M. p. 146 – 147 C. – 1H NMR (300 MHz, D2O): δ =
2.10 − 2.18 (m, 2H, 3-H), 2.46 (t,3J = 6.9 Hz, 2H, 2-
H), 3.22 – 3.28 (m, 2H, 4-H), 4.48 (s, 4H, N-benzyl-CH2),
7.53 – 7.63 (m, 10H, arom. CH). – 13C NMR (75 MHz,
D2O): δ = 19.15 (C-3), 31.12 (C-2), 51.88 (C-4), 57.74
(N-benzyl-CH2), 129.45, 129.86, 130.67, 131.50 (arom. C),
177.15 (CO).
1: 1H NMR (300 MHz, CDCl3): δ = 0.66 − 3.20 (m,
75H, bicyclo-H, CH2, CH3), 7.21 – 7.56 (m, 10H, phenyl-
H), 7.57 – 7.94 (m, 6H, triphenylene-H). – 13C NMR
(75 MHz, CDCl3) (selected signals of 77 detected): δ =
13.96 (CH3), 39.88 (NHCH2), 101.18 (spiro-C), 122.08,
124.48 (triphenylene-C), 129.25, 129.31 (phenyl-C), 147.74
(triphenylene-C). – MS (ESI (ES+)): m/z (%) = 1267.8 (10),
1266.9 (33), 1265.9 (84), 1264.9 (87) [M+H+].
4-(N,N-Dibenzylamino)butyric acid (7) [20]
4-(N,N-Dibenzylamino)butyric acid hydrochloride (6)
(11.00 g, 34.4 mmol) was dissolved in water (250 ml) and
neutralized with aqueous sodium hydroxide solution (20%).
After removal of water under reduced pressure, the residue
was dissolved in chloroform (150 ml) at reflux conditions,
filtered hot and washed with chloroform (3×20 ml). Evapo-
ration of the volatiles yielded a colorless, viscous oil (9.78 g,
34.4 mmol, 100%).
Benzyl 4-(N,N-dibenzylamino)butyrate (5)
1H NMR (300 MHz, CDCl3): δ = 1.75 (tt,3J = 6.6 Hz,
6.6 Hz, 2H, 3-H), 2.20 (t, 3J = 6.6 Hz, 2H, 2-H), 2.12 (t, 3J =
6.6 Hz, 2H, 4-H), 3.60 (s, 4H, N-benzyl-CH2), 7.20 – 7.33
(m, 10H, arom. CH), 12.04 (bs, 1H, COOH). – 13C NMR
(75 MHz, CDCl3): δ = 21.82 (C-3), 34.47 (C-2), 53.05 (C-
4), 58.03 (N-benzyl-CH2), 127.49, 128.42, 129.41 (arom.
CH), 136.94 (quat. C), 177.93 (CO). – MS (EI, 70 eV): m/z
(%) = 283.1 (7) [M+], 210.1 (74) [CH2NBn2+], 91.0 (100)
[C7H7+].
4-Aminobutyric acid (39.95 g, 0.387 mol) was dissolved
in dichloromethane (250 ml), potassium carbonate (72 g,
0.514 mol, 1.3 eq.) and 2 N aqueous sodium hydroxide solu-
tion (100 ml) were added. The biphasic mixture was heated
at reflux conditions and benzyl bromide (170 ml, 1.40 mol,
3.6 eq.) was added drop by drop within 15 min. into the hot
mixture. After 16 h, the mixture was brought to ambient tem-
perature and the aqueous phase was extracted with diethyl
ether (150 ml). The combined organic phases were washed
with brine (2 × 150 ml), dried over anhydrous MgSO4 and
concentrated in vacuo. Excess benzyl bromide was removed
by distillation, 5 (115.55 g, 0.309 mol, 80%) remained as
yellow oil and was used without further purification.
3-(N,N-Dibenzylamino)propyl isocyanate (8)
4-(N,N-Dibenzylamino)butyric
acid
(7)
(4.77 g,
16.8 mmol) was dissolved in dry toluene (125 ml),
treated with triethylamine (2.8 ml, 20.2 mmol, 1.2 eq.),
diphenylphosphoryl azide (DPPA) (4.4 ml, 20.2 mmol,
1.2 eq.) and stirred at ambient temperature for 3 d, followed
by refluxing until gas evaporation was no longer observed.
Upon removal of the solvents under reduced pressure the
remaining oil was purified by distillation in high vacuum
yielding 8 as yellow oil (1.78 g, 6.3 mmol, 38%).
B. p. 154 – 156 ◦C/5×10−5 mbar. – 1H NMR (300 MHz,
CDCl3): δ = 1.81 − 1.89 (m, 2H, 3-H), 3.12 – 3.19, 3.23 –
3.29 (m, 4H, 2-H, 4-H), 4.55, 4.61 (s, 4H, N-benzyl-CH2),
7.21 – 7.33 (m, 10H, arom. CH). – 13C NMR (75 MHz,
CDCl3): δ = 21.82 (C-3), 34.47 (C-2), 53.05 (C-4), 58.03
(N-benzyl-CH2), 127.49, 128.42, 129.41 (arom. C), 136.94
1H NMR (300 MHz, CDCl3): δ = 1.86 (tt, 3J = 6.9 Hz,
3
6.9 Hz, 2H, 3-H), 2.37, 2.47 (2 × t, J = 6.9 Hz, 4H, 2-H,
4-H), 3.56 (s, 4H, N-benzyl-CH2), 5.05 (s, 2H, O-benzyl-
CH2), 7.20 – 7.37 (m, 15H, arom. CH). – 13C NMR (75 MHz,
CDCl3): δ = 22.32 (C-3), 31.88 (C-2), 52.42 (C-4), 58.24
(N-benzyl-CH2), 70.74 (O-benzyl-CH2), 126.84, 126.94,
127.57, 127.73, 128.09, 128.13, 128.16, 128.25, 128.35,
128.49, 128.61, 128.65, 128.74, 128.80, 128.98 (arom. CH),
133.29, 136.09 (quat. C), 173.36 (CO). – MS (EI, 70 eV):
m/z (%) = 373.3 (3) [M+], 282.2 (9) [M+ −Bn], 210.1 (85)
[CH2NBn+2 ], 91.0 (100) [C7H7+].
4-(N,N-Dibenzylamino)butyric acid hydrochloride (6) [20]
A solution of benzyl-4-(N,N-dibenzylamino)-butyrate (5) (quat.-C), 177.93 (CO). – MS (EI, 70 eV): m/z (%) = 280.2
(101.76 g, 0.272 mol) in aqueous potassium hydroxide solu- (67) [M+], 251.1 (5) [M+–CO], 189.1 (62) [M+–C7H7],
tion (20%, 80 ml) was heated at reflux conditions over night. 91.0 (100) [C7H7+], 77.0 (13) [C6H5+].
Brought to you by | University of Otago
Authenticated
Download Date | 12/14/18 7:12 AM